文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

基于对比增强乳腺X线摄影的可解释机器学习模型用于预测乳腺癌分子亚型

Contrast-enhanced mammography-based interpretable machine learning model for the prediction of the molecular subtype breast cancers.

作者信息

Ma Mengwei, Xu Weimin, Yang Jun, Zheng Bowen, Wen Chanjuan, Wang Sina, Xu Zeyuan, Qin Genggeng, Chen Weiguo

机构信息

Department of Radiology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, China.

出版信息

BMC Med Imaging. 2025 Jul 1;25(1):255. doi: 10.1186/s12880-025-01765-3.


DOI:10.1186/s12880-025-01765-3
PMID:40596940
Abstract

OBJECTIVE: This study aims to establish a machine learning prediction model to explore the correlation between contrast-enhanced mammography (CEM) imaging features and molecular subtypes of mass-type breast cancer. MATERIALS AND METHODS: This retrospective study included women with breast cancer who underwent CEM preoperatively between 2018 and 2021. We included 241 patients, which were randomly assigned to either a training or a test set in a 7:3 ratio. Twenty-one features were visually described, including four clinical features and seventeen radiological features, these radiological features which extracted from the CEM. Three binary classifications of subtypes were performed: Luminal vs. non-Luminal, HER2-enriched vs. non-HER2-enriched, and triple-negative (TNBC) vs. non-triple-negative. A multinomial naive Bayes (MNB) machine learning scheme was employed for the classification, and the least absolute shrink age and selection operator method were used to select the most predictive features for the classifiers. The classification performance was evaluated using the area under the receiver operating characteristic curve. We also utilized SHapley Additive exPlanation (SHAP) values to explain the prediction model. RESULTS: The model that used a combination of low energy (LE) and dual-energy subtraction (DES) achieved the best performance compared to using either of the two images alone, yielding an area under the receiver operating characteristic curve of 0.798 for Luminal vs. non-Luminal subtypes, 0.695 for TNBC vs. non-TNBC, and 0.773 for HER2-enriched vs. non-HER2-enriched. The SHAP algorithm shows that "LE_mass_margin_spiculated," "DES_mass_enhanced_margin_spiculated," and "DES_mass_internal_enhancement_homogeneous" have the most significant impact on the model's performance in predicting Luminal and non-Luminal breast cancer. "mass_calcification_relationship_no," "calcification_ type_no," and "LE_mass_margin_spiculated" have a considerable impact on the model's performance in predicting HER2 and non-HER2 breast cancer. CONCLUSIONS: The radiological characteristics of breast tumors extracted from CEM were found to be associated with breast cancer subtypes in our study. Future research is needed to validate these findings.

摘要

目的:本研究旨在建立一种机器学习预测模型,以探讨乳腺造影增强(CEM)成像特征与肿块型乳腺癌分子亚型之间的相关性。 材料与方法:这项回顾性研究纳入了2018年至2021年间术前接受CEM检查的乳腺癌女性患者。我们纳入了241例患者,按照7:3的比例随机分配到训练集或测试集。通过视觉描述了21个特征,包括4个临床特征和17个放射学特征,这些放射学特征是从CEM中提取的。进行了三种亚型的二元分类:Luminal型与非Luminal型、HER2富集型与非HER2富集型、三阴性(TNBC)与非三阴性。采用多项式朴素贝叶斯(MNB)机器学习方案进行分类,并使用最小绝对收缩和选择算子方法为分类器选择最具预测性的特征。使用受试者操作特征曲线下面积评估分类性能。我们还利用SHapley值加法解释(SHAP)来解释预测模型。 结果:与单独使用两张图像中的任何一张相比,使用低能量(LE)和双能量减影(DES)组合的模型表现最佳,Luminal型与非Luminal型亚型的受试者操作特征曲线下面积为0.798,TNBC与非TNBC为0.695,HER2富集型与非HER2富集型为0.773。SHAP算法表明,“LE_mass_margin_spiculated”“DES_mass_enhanced_margin_spiculated”和“DES_mass_internal_enhancement_homogeneous”对模型预测Luminal型和非Luminal型乳腺癌的性能影响最大。“mass_calcification_relationship_no”“calcification_type_no”和“LE_mass_margin_spiculated”对模型预测HER2型和非HER2型乳腺癌的性能有相当大的影响。 结论:在我们的研究中,发现从CEM中提取的乳腺肿瘤放射学特征与乳腺癌亚型有关。未来需要进一步研究来验证这些发现。

相似文献

[1]
Contrast-enhanced mammography-based interpretable machine learning model for the prediction of the molecular subtype breast cancers.

BMC Med Imaging. 2025-7-1

[2]
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

Health Technol Assess. 2006-9

[3]
Multiparametric MRI-based Interpretable Machine Learning Radiomics Model for Distinguishing Between Luminal and Non-luminal Tumors in Breast Cancer: A Multicenter Study.

Acad Radiol. 2025-4-1

[4]
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?

Clin Orthop Relat Res. 2024-9-1

[5]
Machine-learning model based on ultrasomics for non-invasive evaluation of fibrosis in IgA nephropathy.

Eur Radiol. 2025-1-24

[6]
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Cochrane Database Syst Rev. 2021-4-19

[7]
Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk.

Cochrane Database Syst Rev. 2023-3-31

[8]
Serum calcium-based interpretable machine learning model for predicting anastomotic leakage after rectal cancer resection: A multi-center study.

World J Gastroenterol. 2025-5-21

[9]
Interpretable machine learning for predicting isolated basal septal hypertrophy.

PLoS One. 2025-6-30

[10]
A Machine Learning Model for Predicting the HER2 Positive Expression of Breast Cancer Based on Clinicopathological and Imaging Features.

Acad Radiol. 2025-7

本文引用的文献

[1]
Diagnosis, Prognosis, and Treatment of Triple-Negative Breast Cancer: A Review.

Breast Cancer (Dove Med Press). 2025-3-17

[2]
Enhancing HER2 testing in breast cancer: predicting fluorescence in situ hybridization (FISH) scores from immunohistochemistry images via deep learning.

J Pathol Clin Res. 2025-3

[3]
Triple-Negative Breast Cancer: Molecular Particularities Still a Challenge.

Diagnostics (Basel). 2024-8-27

[4]
The potential role of breast MRI in evaluation of triple-negative breast cancer and fibroadenoma of less than 3 cm.

Transl Cancer Res. 2024-8-31

[5]
Investigation of breast cancer molecular subtype in a multi-ethnic population using MRI.

PLoS One. 2024

[6]
Human epidermal growth factor receptor 2 (HER2) status in breast cancer: practice points and challenges.

Histopathology. 2024-9

[7]
Contrast-enhanced Mammography versus MR Imaging of the Breast.

Radiol Clin North Am. 2024-7

[8]
SHAP value-based ERP analysis (SHERPA): Increasing the sensitivity of EEG signals with explainable AI methods.

Behav Res Methods. 2024-9

[9]
Enhancing Ki-67 Prediction in Breast Cancer: Integrating Intratumoral and Peritumoral Radiomics From Automated Breast Ultrasound via Machine Learning.

Acad Radiol. 2024-7

[10]
Machine learning-based models for the prediction of breast cancer recurrence risk.

BMC Med Inform Decis Mak. 2023-11-29

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索